14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $5.34 $19.02 Monday, 6th May 2024 CNTA stock ended at $9.25. This is 2.32% less than the trading day before Friday, 3rd May 2024. During the day the stock fluctuated 2.81% from a day low at $9.24 to a day high of $9.50.
90 days $17.30 $19.02
52 weeks $16.32 $20.85

Historical Centessa Pharmaceuticals Limited prices

Date Open High Low Close Volume
Apr 01, 2024 $11.47 $11.48 $10.56 $11.08 244 661
Mar 28, 2024 $11.06 $11.47 $10.82 $11.30 172 148
Mar 27, 2024 $10.76 $11.23 $10.39 $11.10 68 505
Mar 26, 2024 $11.58 $11.80 $10.71 $10.76 104 695
Mar 25, 2024 $12.20 $12.40 $11.06 $11.51 446 453
Mar 22, 2024 $12.16 $12.40 $11.89 $12.20 160 988
Mar 21, 2024 $11.88 $12.41 $11.85 $12.08 258 281
Mar 20, 2024 $11.24 $11.85 $10.89 $11.84 553 088
Mar 19, 2024 $10.64 $11.23 $10.24 $11.17 323 814
Mar 18, 2024 $10.83 $10.93 $10.27 $10.62 267 591
Mar 15, 2024 $10.48 $10.94 $10.30 $10.75 214 985
Mar 14, 2024 $10.89 $10.89 $10.43 $10.47 167 992
Mar 13, 2024 $10.93 $11.10 $10.80 $10.85 74 095
Mar 12, 2024 $9.79 $10.96 $9.79 $10.86 195 281
Mar 11, 2024 $10.93 $10.93 $9.71 $9.75 249 957
Mar 08, 2024 $11.10 $11.31 $10.96 $11.03 84 835
Mar 07, 2024 $11.26 $11.62 $10.80 $11.06 204 308
Mar 06, 2024 $11.13 $11.15 $10.57 $11.03 141 625
Mar 05, 2024 $11.19 $11.19 $10.54 $10.89 153 262
Mar 04, 2024 $11.09 $11.20 $10.75 $11.17 214 920
Mar 01, 2024 $10.54 $11.00 $10.28 $10.87 260 722
Feb 29, 2024 $10.74 $10.74 $10.14 $10.51 86 437
Feb 28, 2024 $11.23 $11.49 $10.30 $10.44 114 526
Feb 27, 2024 $11.31 $11.66 $11.00 $11.36 187 214
Feb 26, 2024 $11.00 $11.80 $11.00 $11.29 281 767
Click to get the best stock tips daily for free!

About Centessa Pharmaceuticals Limited

Centessa Pharmaceuticals Limited Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; and SerpinPC, an activated protein C inhibitor, which is in Phase IIa clinical development for the treatm... CNTA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT